Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 27, 2021Nature CommunicationsOpen Access

Copy number signatures predict chromothripsis and clinical outcomes in newly diagnosed multiple myeloma

View Full Paper
Ask AI
Bookmark
Share

Authors

KMKylee MaclachlanMemorial Sloan Kettering Cancer CenterEREven H RustadOslo University HospitalADAndriy DerkachMemorial Sloan Kettering Cancer Center

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Maclachlan et al. (2021) studied this question.

synapsesocial.com/papers/6a10ed6263b25c787d9fb969https://doi.org/10.1038/s41467-021-25469-8
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Patterns of genomic loss of heterozygosity predict homologous recombination repair defects in epithelial ovarian cancer2012 · 875 citations
  2. 2Control-FREEC: a tool for assessing copy number and allelic content using next-generation sequencing data2011 · 1,111 citations
  3. 3Accelerated single cell seeding in relapsed multiple myeloma2020 · 80 citations
  4. 4Genomic landscape and chronological reconstruction of driver events in multiple myeloma2019 · 280 citations
  5. 5A practical guide for mutational signature analysis in hematological malignancies2019 · 206 citations